Jeremy Thomas

5.1k total citations
90 papers, 2.2k citations indexed

About

Jeremy Thomas is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Jeremy Thomas has authored 90 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cancer Research, 44 papers in Oncology and 31 papers in Pathology and Forensic Medicine. Recurrent topics in Jeremy Thomas's work include Breast Cancer Treatment Studies (52 papers), Breast Lesions and Carcinomas (29 papers) and HER2/EGFR in Cancer Research (19 papers). Jeremy Thomas is often cited by papers focused on Breast Cancer Treatment Studies (52 papers), Breast Lesions and Carcinomas (29 papers) and HER2/EGFR in Cancer Research (19 papers). Jeremy Thomas collaborates with scholars based in United Kingdom, Canada and United States. Jeremy Thomas's co-authors include John M.S. Bartlett, J. Michael Dixon, David Cameron, Dana Faratian, J. Michael Dixon, Lorna Renshaw, David J. Harrison, Alison F. Munro, Simon P. Langdon and W Jack and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Biomaterials.

In The Last Decade

Jeremy Thomas

86 papers receiving 2.1k citations

Peers

Jeremy Thomas
Guang‐Yu Liu China
In Ae Park South Korea
Tracy Lively United States
Eun‐Kyu Kim South Korea
Tadahiko Shien Japan
Han‐Sung Kang South Korea
Xiaosong Chen China
Kenzo Shimazu Japan
Marc Thill Germany
Iain D. Miller United Kingdom
Guang‐Yu Liu China
Jeremy Thomas
Citations per year, relative to Jeremy Thomas Jeremy Thomas (= 1×) peers Guang‐Yu Liu

Countries citing papers authored by Jeremy Thomas

Since Specialization
Citations

This map shows the geographic impact of Jeremy Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy Thomas more than expected).

Fields of papers citing papers by Jeremy Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy Thomas. The network helps show where Jeremy Thomas may publish in the future.

Co-authorship network of co-authors of Jeremy Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy Thomas. A scholar is included among the top collaborators of Jeremy Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy Thomas. Jeremy Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonnefoi, Hervé, Gaëtan MacGrogan, Coralie Poncet, et al.. (2019). Molecular apocrine tumours in EORTC 10994/BIG 1-00 phase III study: pathological response after neoadjuvant chemotherapy and clinical outcomes. British Journal of Cancer. 120(9). 913–921. 13 indexed citations
2.
Dixon, J. Michael, David Cameron, Laura Arthur, et al.. (2019). Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical Studies. Advances in Therapy. 36(4). 828–841. 12 indexed citations
3.
Dessauvagie, Benjamin F., Andrew H.S. Lee, Katie Meehan, et al.. (2018). Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology. Journal of Clinical Pathology. 71(8). 672–679. 19 indexed citations
4.
Maxwell, Anthony, Karen Clements, Bridget Hilton, et al.. (2018). Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ. European Journal of Surgical Oncology. 44(4). 429–435. 66 indexed citations
5.
Thomas, Jeremy, A M Hanby, Nicola S. Russell, et al.. (2017). The BIG 2.04 MRC/EORTC SUPREMO Trial: pathology quality assurance of a large phase 3 randomised international clinical trial of postmastectomy radiotherapy in intermediate-risk breast cancer. Breast Cancer Research and Treatment. 163(1). 63–69. 14 indexed citations
6.
Ali, Hager R., A. Dariush, Jeremy Thomas, et al.. (2017). Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial. Annals of Oncology. 28(8). 1832–1835. 31 indexed citations
7.
Dixon, J. Michael, et al.. (2016). A study of margin width and local recurrence in breast conserving therapy for invasive breast cancer. European Journal of Surgical Oncology. 42(5). 657–664. 12 indexed citations
8.
Thomas, Jeremy, et al.. (2016). Benchmarking a large regional UK HER2 testing service against current practice guidelines. Journal of Clinical Pathology. 70(5). 378–382.
9.
Arthur, Laura, Arran Turnbull, Alexey A. Larionov, et al.. (2014). Molecular Changes in Lobular Breast Cancers in Response to Endocrine Therapy. Cancer Research. 74(19). 5371–5376. 25 indexed citations
10.
Huang, Rui, Dana Faratian, Andrew H. Sims, et al.. (2014). Increased STAT1 Signaling in Endocrine-Resistant Breast Cancer. PLoS ONE. 9(4). e94226–e94226. 32 indexed citations
11.
Thomas, Jeremy, Andrew M. Hanby, Sarah E. Pinder, et al.. (2014). Adverse surgical outcomes in screen-detected ductal carcinoma in situ of the breast. European Journal of Cancer. 50(11). 1880–1890. 12 indexed citations
12.
Spears, Melanie, Jeremy Thomas, G.R. Kerr, et al.. (2012). Expression of activated type I receptor tyrosine kinases in early breast cancer. Breast Cancer Research and Treatment. 134(2). 701–708. 3 indexed citations
13.
Williams, Linda, Jeremy Thomas, J. Michael Dixon, et al.. (2011). Determining tamoxifen sensitivity using primary breast cancer tissue in collagen-based three-dimensional culture. Biomaterials. 33(3). 907–915. 19 indexed citations
14.
Bartlett, John M.S., Fiona Campbell, Merdol Ibrahim, et al.. (2010). A UK NEQAS ICC and ISH multicentre study using the Kreatech Poseidon HER2 FISH probe: intersite variation can be rigorously controlled using FISH. Histopathology. 56(3). 297–304. 8 indexed citations
15.
16.
Bartlett, John M.S., Alison F. Munro, David Cameron, et al.. (2008). Type 1 Receptor Tyrosine Kinase Profiles Identify Patients With Enhanced Benefit From Anthracyclines in the BR9601 Adjuvant Breast Cancer Chemotherapy Trial. Journal of Clinical Oncology. 26(31). 5027–5035. 67 indexed citations
17.
18.
Thomas, Jeremy, Andrew M. Hanby, Sarah E. Pinder, et al.. (2008). Implications of Inconsistent Measurement of ER Status in Non-Invasive Breast Cancer: A Study of 1,684 Cases from the Sloane Project. The Breast Journal. 14(1). 33–38. 15 indexed citations
19.
Dixon, J. Michael, Dana Faratian, Sharon White, et al.. (2007). DCIS and aromatase inhibitors. The Journal of Steroid Biochemistry and Molecular Biology. 106(1-5). 173–179. 6 indexed citations
20.
Dixon, J. Michael, et al.. (2004). Node retrieval in axillary lymph node dissections: recommendations for minimum numbers to be confident about node negative status. Journal of Clinical Pathology. 57(8). 845–848. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guang‐Yu Liu Breakdown of academic impact, for papers by In Ae Park Breakdown of academic impact, for papers by Tracy Lively Breakdown of academic impact, for papers by Eun‐Kyu Kim Breakdown of academic impact, for papers by Tadahiko Shien Breakdown of academic impact, for papers by Han‐Sung Kang Breakdown of academic impact, for papers by Xiaosong Chen Breakdown of academic impact, for papers by Kenzo Shimazu Breakdown of academic impact, for papers by Marc Thill Breakdown of academic impact, for papers by Iain D. Miller
Rankless by CCL
2026